MX2017004319A - Metodos para el tratamiento de la periimplantitis. - Google Patents

Metodos para el tratamiento de la periimplantitis.

Info

Publication number
MX2017004319A
MX2017004319A MX2017004319A MX2017004319A MX2017004319A MX 2017004319 A MX2017004319 A MX 2017004319A MX 2017004319 A MX2017004319 A MX 2017004319A MX 2017004319 A MX2017004319 A MX 2017004319A MX 2017004319 A MX2017004319 A MX 2017004319A
Authority
MX
Mexico
Prior art keywords
implant
peri
bone
treatment
methods
Prior art date
Application number
MX2017004319A
Other languages
English (en)
Other versions
MX376429B (es
Inventor
Emanuel Noam
Original Assignee
Polypid Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polypid Ltd filed Critical Polypid Ltd
Publication of MX2017004319A publication Critical patent/MX2017004319A/es
Publication of MX376429B publication Critical patent/MX376429B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/50—Preparations specially adapted for dental root treatment
    • A61K6/58—Preparations specially adapted for dental root treatment specially adapted for dental implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A61K6/864—Phosphate cements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/891—Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invencion se relaciona con composiciones farmaceuticas y metodos para el tratamiento de enfermedades periimplantarias, en particular enfermedades periimplantarias caracterizadas por la destruccion de la cresta del hueso alveolar que sostiene el implante. Especificamente, el metodo comprende la etapa de aplicar a un hueso periimplantario que muestra resorcion crestal una composicion farmaceutica que comprende material de aumento oseo biocompatible recubierto con una composicion de matriz que proporciona una liberacion controlada y prolongada local de al menos un agente farmaceuticamente activo en el sitio de perdida osea.
MX2017004319A 2014-10-02 2015-09-27 Metodos para el tratamiento de la periimplantitis MX376429B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462059116P 2014-10-02 2014-10-02
PCT/IB2015/057410 WO2016051322A1 (en) 2014-10-02 2015-09-27 Methods for the treatment of peri-implantitis

Publications (2)

Publication Number Publication Date
MX2017004319A true MX2017004319A (es) 2017-05-19
MX376429B MX376429B (es) 2025-03-07

Family

ID=55629499

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004319A MX376429B (es) 2014-10-02 2015-09-27 Metodos para el tratamiento de la periimplantitis

Country Status (15)

Country Link
US (1) US10758639B2 (es)
EP (1) EP3200749B1 (es)
JP (1) JP2017531461A (es)
KR (1) KR102466337B1 (es)
CN (1) CN107072885B (es)
AU (1) AU2015326429B2 (es)
BR (1) BR112017006402B1 (es)
CA (1) CA2961998C (es)
EA (1) EA038147B1 (es)
IL (1) IL251345B (es)
MX (1) MX376429B (es)
NZ (1) NZ729628A (es)
PH (1) PH12017500570A1 (es)
SG (1) SG11201702700UA (es)
WO (1) WO2016051322A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110856702A (zh) * 2018-08-23 2020-03-03 上海利康消毒高科技有限公司 种植牙口腔护理凝胶及其制备方法
JP7402339B2 (ja) * 2019-12-04 2023-12-20 デイタム デンタル リミテッド 非外科的方法で歯周を治療するためのコラーゲン－ヒドロキシアパタイトデバイス
US20230130132A1 (en) * 2020-03-26 2023-04-27 Bone Sci. Bio Ltd. Pharmaceutical compositions comprising amphiphilic peptides and methods of use thereof
KR102439762B1 (ko) 2021-03-09 2022-09-02 주식회사 오라팜 임플란트 주위점막염 예방 및 치료 조성물
KR102752150B1 (ko) 2022-12-22 2025-01-09 이종호 임플란트용 픽스쳐 절삭기구
DE102023100442A1 (de) 2023-01-10 2024-07-11 Hubertus Platt Verfahren und Vorrichtung zur vorbeugenden Behandlung von Periimplantitis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518359A (ja) * 1997-10-07 2001-10-16 ドクトル．ハー．ツェー．ロベルト マシーズ スティフツング 外科用水硬セメント
US6425949B1 (en) * 1997-10-07 2002-07-30 Dr. H. C. Robert Mathys Stiftung Hydraulic surgical cement
EP2143451A1 (en) 2008-07-11 2010-01-13 Nobel Biocare Services AG Bone implant application
JP5681626B2 (ja) * 2008-07-14 2015-03-11 ポリーペイド リミテッドＰｏｌｙｐｉｄ Ｌｔｄ． 徐放性薬剤キャリア組成物
CN102470105B (zh) * 2009-07-14 2015-07-29 波利皮得有限公司 持续释放药物载体组合物
NL1039169C2 (en) * 2011-11-15 2013-05-16 Kamosi Hoshang Peri-implant ultrasound debridement device (pius-dd).
NZ704066A (en) 2012-08-02 2017-06-30 Polypid Ltd Compositions and methods for the treatment of bone voids and open fractures

Also Published As

Publication number Publication date
US10758639B2 (en) 2020-09-01
KR102466337B1 (ko) 2022-11-14
IL251345B (en) 2021-05-31
EA038147B1 (ru) 2021-07-13
PH12017500570A1 (en) 2017-08-30
JP2017531461A (ja) 2017-10-26
SG11201702700UA (en) 2017-04-27
EP3200749A1 (en) 2017-08-09
KR20170101890A (ko) 2017-09-06
EP3200749A4 (en) 2018-05-23
IL251345A0 (en) 2017-05-29
EA201790382A1 (ru) 2017-08-31
EP3200749B1 (en) 2020-09-02
MX376429B (es) 2025-03-07
US20170246342A1 (en) 2017-08-31
BR112017006402B1 (pt) 2021-03-02
CN107072885A (zh) 2017-08-18
BR112017006402A2 (pt) 2017-12-19
AU2015326429B2 (en) 2020-11-12
WO2016051322A1 (en) 2016-04-07
CA2961998C (en) 2022-07-26
CA2961998A1 (en) 2016-04-07
CN107072885B (zh) 2021-08-17
NZ729628A (en) 2023-02-24
AU2015326429A1 (en) 2017-03-23

Similar Documents

Publication Publication Date Title
PH12017500570A1 (en) Methods for the treatment of peri-implantitis
NI201700011A (es) 2-(morfolin-4-il)-1,7-naftiridinas.
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
NI201600051A (es) Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
MX2019003173A (es) Terapia de combinacion con agonistas de peptido natriuretico tipo c (cnp) de liberacion controlada.
MX2017004318A (es) Composiciones y metodos para el tratamiento y profilaxis de infecciones del sitio quirurgico.
ECSP17085443A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma
BR112015022161A2 (pt) implante intraocular contendo prostamida
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
PY1884718A (es) Composición de hidrogel a base de ácido hialurónico estabilizada farmacéuticamente y método de preparación de esta
MX2018007048A (es) Composiciones para el cuidado bucal que comprenden al menos un copolimero de fosfato / acrilato y al menos un ingrediente activo cationico.
CL2017002006A1 (es) Implante dental para facilitar y estabilizar la implantacion.
CO2021012893A2 (es) Polímero superabsorbente y método para aumentar el contenido de azúcar en plantas
MX2019000717A (es) Composiciones que comprenden una matriz de polisacarido para la liberacion controlada de ingredientes activos.
MX2011012045A (es) Composiciones con liberacion rapida de farmaco.
SV2016005308A (es) Composiciã“n farmacã‰utica para el tratamiento de alopatã�as relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
MX2019004414A (es) Un nuevo metodo para producir hemihidrato de sulfato de calcio con propiedades unicas.
EP3360562A4 (en) Pharmaceutical composition for promoting periodontal tissue growth and for prevention and treatment of periodontitis, containingmagnolia flower
UY36598A (es) Composición para el tratamiento de neuropatías y/o dolor neuropático
AR112844A1 (es) Composición de hidrogel a base de ácido hialurónico estabilizada farmacéuticamente y método de preparación de esta
RU2014142229A (ru) Способ ускорения процесса репаративного остеогенеза
MX2016016635A (es) Desmopresina estabilizada.
UA126148U (uk) Спосіб лікування періімплантного мукозиту
MX2017002700A (es) Composicion farmaceutica para el tratamiento de dolor agudo de dientes o de mandibula.

Legal Events

Date Code Title Description
FG Grant or registration